We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

162 hedge funds and large institutions have $1.47B invested in Acorda Therapeutics in 2014 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 63 increasing their positions, 45 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 15

40% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 45

7% more funds holding

Funds holding: 152 → 162 (+10)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less capital invested

Capital invested by funds: $1.57B → $1.47B (-$95M)

38% less call options, than puts

Call options by funds: $2.85M | Put options by funds: $4.62M

Holders
162
Holders Change
+10
Holders Change %
+6.58%
% of All Funds
4.66%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
26
Increased
63
Reduced
45
Closed
15
Calls
$2.85M
Puts
$4.62M
Net Calls
-$1.77M
Net Calls Change
-$2.7M

Top Buyers

Rank Fund Capital Flow
1
BM
Bridger Management
New York
+$38.1M
2
Millennium Management
Millennium Management
New York
+$24M
3
Citadel Advisors
Citadel Advisors
Florida
+$19.2M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$15.4M
5
Jennison Associates
Jennison Associates
New York
+$14.3M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$35.7M
2
Goldman Sachs
Goldman Sachs
New York
-$29.3M
3
PHS
PFM Health Sciences
California
-$27.4M
4
TSW
Thompson Siegel & Walmsley
Virginia
-$22.3M
5
Invesco
Invesco
Georgia
-$13.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
GAM
76
Gotham Asset Management
New York
$1.73M +$1.74M +427 New
MOACM
77
Mutual of America Capital Management
New York
$1.69M -$102K -25 -6%
Stifel Financial
78
Stifel Financial
Missouri
$1.68M +$114K +28 +7%
RhumbLine Advisers
79
RhumbLine Advisers
Massachusetts
$1.68M -$8.15K -2 -0.5%
ProShare Advisors
80
ProShare Advisors
Maryland
$1.65M -$889K -218 -35%
NFA
81
Nationwide Fund Advisors
Ohio
$1.65M +$20.4K +5 +1%
State Board of Administration of Florida Retirement System
82
State Board of Administration of Florida Retirement System
Florida
$1.61M – – –
Two Sigma Advisers
83
Two Sigma Advisers
New York
$1.5M +$159K +39 +12%
Susquehanna International Group
84
Susquehanna International Group
Pennsylvania
$1.5M -$212K -52 -12%
Swiss National Bank
85
Swiss National Bank
Switzerland
$1.48M – – –
DCM
86
Dupont Capital Management
Delaware
$1.46M -$444K -109 -23%
Comerica Bank
87
Comerica Bank
Texas
$1.42M -$8.15K -2 -0.6%
TPSF
88
Texas Permanent School Fund
Texas
$1.42M +$16.3K +4 +1%
Renaissance Technologies
89
Renaissance Technologies
New York
$1.4M -$5.98M -1,467 -81%
Axa
90
Axa
France
$1.4M -$57.1K -14 -4%
PP
91
PDT Partners
New York
$1.29M +$89.7K +22 +7%
GC
92
Globeflex Capital
California
$1.25M – – –
GCP
93
GSA Capital Partners
United Kingdom
$1.22M +$722K +177 +140%
State of Tennessee, Department of Treasury
94
State of Tennessee, Department of Treasury
Tennessee
$1.2M -$53K -13 -4%
VRS
95
Virginia Retirement Systems
Virginia
$1.16M +$61.2K +15 +5%
PA
96
Profund Advisors
Maryland
$1.15M -$204K -50 -15%
TC
97
TFS Capital
Pennsylvania
$1.11M +$689K +169 +161%
WT
98
Whittier Trust
California
$1.1M – – –
JP Morgan Chase
99
JP Morgan Chase
New York
$1.1M +$1.11M +273 New
MLICM
100
Metropolitan Life Insurance Company (MetLife)
New York
$1.09M – – –
2 3
4
5 6

ACOR Hedge Fund Activity: Q2 2014 in Review

162 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q2 2014, worth a combined $1.47B — down 6.1% from $1.57B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ACOR positions and 15 closed out — a net gain of 11 holders — while 63 added to existing stakes and 45 trimmed.

The largest buyer was Bridger Management, opening a new position worth an estimated $38.1M. The largest seller was Franklin Resources, exiting entirely with an estimated $35.7M sold.

  • 162 institutional investors held Acorda Therapeutics (ACOR) as of Q2 2014, up from 152 in Q1 2014.
  • Funds reported $1.47B of Acorda Therapeutics stock for Q2 2014, down 6.1% quarter-over-quarter.
  • 26 funds opened new Acorda Therapeutics positions in Q2 2014 and 15 closed out, a net change of +11 holders.
  • The largest Acorda Therapeutics buyer in Q2 2014 was Bridger Management, an estimated $38.1M added.
  • The largest Acorda Therapeutics seller in Q2 2014 was Franklin Resources, an estimated $35.7M sold.

Based on aggregated 13F filings for Q2 2014.